Tumour biology and pathology
3P - Notable variation of molecular testing in metastatic lung cancer in the Netherlands
Authors
- C. Epskamp-Kuijpers (Utrecht, Netherlands)
- M. Van den Heuvel (Nijmegen, Netherlands)
- L. Overbeek (Houten, Netherlands)
- A. Van Lindert (Utrecht, Netherlands)
- R. Damhuis (Utrecht, Netherlands)
- S. Willems (Utrecht, Netherlands)
Speakers
- C. Epskamp-Kuijpers (Utrecht, Netherlands)
Tumour biology and pathology
4P - Correlation between folate receptor alpha (FRα) expression and clinicopathological features in lung adenocarcinoma
Authors
- N. Tamura (Tokyo, Japan)
- Y. Fujiwara (Tokyo, Japan)
- T. Hashimoto (Tokyo, Japan)
- H. Shiraishi (Tokyo, Japan)
- S. Kitano (Tokyo, NY, Japan)
- T. Shimizu (Tokyo, Japan)
- N. Yamamoto (Tokyo, Japan)
- N. Motoi (Tokyo, Japan)
Speakers
- N. Tamura (Tokyo, Japan)
Tumour biology and pathology
5P - The circular RNA circXPO1 promotes tumor growth in lung adenocarcinoma
Authors
- Q. Huang (Beijing, China)
- M. Qiu (Beijing, China)
Speakers
- Q. Huang (Beijing, China)
Tumour biology and pathology
7P - Immunomodulatory effects of Tumor Treating Fields (TTFields) on lung cancer models
Authors
- U. Weinberg (Luzern, Switzerland)
- N. Kaynan (Haifa, Israel)
- T. Voloshin Sela (Haifa, Israel)
- S. Davidi (Haifa, Israel)
- Y. Porat (Haifa, Israel)
- A. Shteingauz (Haifa, Israel)
- M. Munster (Haifa, Israel)
- R. Schneiderman (Haifa, Israel)
- C. Tempel Brami (Haifa, Israel)
- E. Zeevi (Haifa, Israel)
- K. Gotlib (Haifa, Israel)
- S. Cahal (Haifa, Israel)
- M. Giladi (Haifa, Israel)
- E. Kirson (Haifa, Israel)
- A. Kinzel (München, Germany)
- Y. Palti (Haifa, Israel)
Speakers
- U. Weinberg (Luzern, Switzerland)
Tumour biology and pathology
8P - Role of chemokines in resectable non-small cell lung cancer (NSCLC)
Authors
- M. Drosslerová (Prague, Czech Republic)
- M. Šterclová (Prague, Czech Republic)
- M. Vašáková (Prague, Czech Republic)
- A. Tašková (Prague, Czech Republic)
- V. Hytych (Prague, Czech Republic)
- P. Horažďovský (Prague, Czech Republic)
- E. Richterová (Prague, Czech Republic)
- M. Smětáková (Prague, Czech Republic)
- L. Havel (Prague, Czech Republic)
Speakers
- M. Drosslerová (Prague, Czech Republic)
Tumour biology and pathology
9P - Clinical validation of an NGS-based assay for detecting multiple genomic alterations in Chinese patients with non-small cell lung cancer
Authors
- H. Ge (Xiamen, China)
- X. Chen (Fuzhou, China)
- L. Ruan (Xiamen, China)
- Q. Gao (Xiamen, China)
- X. Yang (Xiamen, China)
- W. Shi (Xiamen, China)
- X. Li (Xiamen, China)
- G. Zhu (Xiamen, China)
Speakers
- H. Ge (Xiamen, China)
Tumour biology and pathology
10P - The prevalence and prognostic significance of JAK2 mutation subtypes in non-small cell lung cancer from Chinese populations
Authors
- W. Wang (Zhenjiang, China)
- C. Xu (Fuzhou, China)
- Q. Zhang (Fuzhou, China)
- W. Zhuang (Fuzhou, China)
- Y. Zhu (Zhenjiang, China)
- Z. Huang (Fuzhou, China)
- G. Chen (Fuzhou, China)
- M. Fang (Zhenjiang, China)
- T. Lv (Nanjing, China)
- Y. Song (Nanjing, China)
Speakers
- W. Wang (Zhenjiang, China)
Tumour biology and pathology
12P - Clinicopathologic characteristics of patients with TP63 mutations in Chinese non-small cell lung cancer
Authors
- Q. Zhang (Fuzhou, China)
- C. Xu (Fuzhou, China)
- W. Wang (Zhenjiang, China)
- W. Zhuang (Fuzhou, China)
- Z. Huang (Fuzhou, China)
- G. Chen (Fuzhou, China)
- M. Fang (Zhenjiang, China)
- T. Lv (Nanjing, China)
- Y. Song (Nanjing, China)
Speakers
- Q. Zhang (Fuzhou, China)
Tumour biology and pathology
13P - The micro-environmental cross talk between mast cells and lung cancer cells through cell-to-cell contact
Authors
- R. Shemesh (Tel Aviv, Israel)
- Y. Gorzalczany (Tel Aviv, Israel)
- R. Sagi-Eisenberg (Tel Aviv, Israel)
- S. Geva (Tel Aviv, Israel)
- L. Roisman (Beer Sheva, Israel)
- N. Peled (Beer Sheva, Israel)
Speakers
- R. Shemesh (Tel Aviv, Israel)
Tumour biology and pathology
14P - The characteristics of MET exon 14 skipping mutations in Chinese non-small cell lung cancer: A retrospective analysis
Authors
- Y. Zhu (Zhenjiang, China)
- C. Xu (Fuzhou, China)
- W. Wang (Zhenjiang, China)
- Q. Zhang (Fuzhou, China)
- W. Zhuang (Fuzhou, China)
- G. Chen (Fuzhou, China)
- M. Fang (Zhenjiang, China)
- T. Lv (Nanjing, China)
- Y. Song (Nanjing, China)
Speakers
- Y. Zhu (Zhenjiang, China)
Tumour biology and pathology
15P - TTF1 status in non-small cell lung cancer adenocarcinoma: A prognostic factor
Authors
- J. Cordoba Ortega (Lleida, Spain)
- A. Salud (Lerida, Spain)
- S. Morales (Lerida, Spain)
- J. Veas (Lerida, Spain)
- A. Rodriguez (Lerida, Spain)
Speakers
- J. Cordoba Ortega (Lleida, Spain)
Tumour biology and pathology
18P - Immunohistochemical expression of PD-L1 in early and late stage non-small cell lung cancer: Correlation with clinicopathological and molecular features
Authors
- E. Kokkotou (Athens, Greece)
- V. Rapti (Athens, Greece)
- D. Grapsa (Athens, Greece)
- P. Bakakos (Athens, Greece)
- S. Papadopoulos (Athens, Greece)
- M. Bobos (Athens, Greece)
- K. Iliadis (Athens, Greece)
- K. Syrigos (Athens, Greece)
Speakers
- E. Kokkotou (Athens, Greece)